Chattanooga Oncology Hematology Associates P.C.

Chattanooga, Tennessee 37404

0 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, Breast Neoplasm, Carcinoma of Unknown Primary, Carcinoma, Non-small Cell, Kidney Neoplasms, Ovarian Neoplasms

Studies at this site

• TAC Versus TC for Adjuvant Breast Cancer — Completed
• Axitinib (AG 013736) As Second Line Therapy For Metastatic Renal Cell Cancer — Completed
• Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung — Completed
• Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary — Completed
• TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer — Completed
• Comparison of Safety and Efficacy of TOCOSOL(R) Paclitaxel Versus Taxol(R) for Treatment of Metastatic Breast Cancer — Stopped early